Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· November 13, 2025

Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025

View original at globenewswire.com
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025 Haverford, PA, Nov…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • SAFETek has more than 1,500 mining machines ready for deployment, giving flexibility to quickly scale production

    80% confidence
  • The company is aggressively responding to negative trends by rolling-out planned initiatives designed to expand sales network and diversify product and service offerings

    80% confidence
  • SAFETek produced 7.87 Bitcoin despite increased network difficulty and energy restrictions, supported by new-generation ASIC deployments and debt-free equipment ownership

    80% confidence
  • Renu Labs delivered $1.1 million in net revenue, with investments in technology and personnel improving productivity and scalability

    80% confidence
  • Opencash Securities is progressing toward the launch of its Opencash app, to offer low-cost commission-free trading for retail and professional investors

    80% confidence
  • Share repurchases have reduced total common shares outstanding by 0.55% to 1,848,994,024 shares as of November 7, 2025

    80% confidence
  • The underlying nuclear energy enterprise offers significant long-term commercial potential but remains in early development stage with no assurance of achieving commercial objectives

    80% confidence
  • iGenius generated $7.1 million in net revenue while preparing to integrate health and wellness offerings from myLife Wellness

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com